Aromatase Inhibitors vs. Tamoxifen: What Should Women Do?
芳香酶抑制剂比他莫昔芬：女性应该做什么？
Hormone therapy includes tamoxifen and aromatase inhibitors.
激素治疗包括三苯氧胺和芳香酶抑制剂。
Tamoxifen (also called Nolvadex) is the most commonly prescribed agent.
他莫西芬是内分泌疗法中最常用的药物。
After that, she is put on the anti-estrogen Tamoxifen for five years.
之后，她服用抗雌激素的三苯氧胺长达五年。
She now takes Tamoxifen, an estrogen-blocking pill, to reduce her risk of recurrence.
现在她通过服用它莫西芬和一种抗雌性激素的药物来降低复发风险。
Letrozole may be used for postmenopausal women who have completed 5 yr of daily tamoxifen.
来曲唑可用于连续5年、每天服用三苯氧胺的绝经后妇女。
'This is simply a situation in which [Seroxat] impairs the effectiveness of tamoxifen,' they said.
“这里的情况很简单，【塞尔特】削弱了它莫西芬的效用。”研究者说。
Cancer has been around longer and drugs like tamoxifen for breast cancer don't have to cost a packet.
人们对癌症早已不再陌生，所以像它莫西芬这样治疗乳腺癌的药也不会贵到让人倾家荡产。
This observation has not been confirmed by other trials employing long term tamoxifen treatment.
这个观察结果还未被其他使用他莫西酚进行治疗的实验所证实。
Objective To observe the antioxidant activity of Tamoxifen(TAM) on human breast cancer cells in vitro.
目的利用体外培养的人乳腺癌细胞检测他莫昔芬的抗氧化活性。
Objective To observe the antioxidant activity of Tamoxifen(TAM) on human breast cancer cells in vitro.
目的 ：通过体外细胞研究 ，观察类胡萝卜素和维甲酸对人乳腺癌细胞的作用。
Tamoxifen has been shown to reduce the recurrence of ER-positive breast cancer when used after primary treatment.
在一期治疗之后服用，Tamoxifen可以降低雌激素阳性乳腺癌的复发。
Rethinking prescriptions. Many women who take tamoxifen to prevent a return of breast cancer also take an antidepressant.
对药物处方的重新思量：许多使用他莫昔芬以预防乳腺癌复发的女性同时使用抗抑郁药物。
Unlike tamoxifen, aromatase inhibitors do not cause menopausal symptoms, but they may increase risk of osteoporosis.
与三苯氧胺不同的是，芳香抑制剂不会引起绝经期症状，但可增加骨质疏松症危险。
All were taking tamoxifen and one of five anti-depressants, including Seroxat, which was the most commonly prescribed.
她们全体都服用它莫西芬，而其中有五分之一服用抗抑郁药品，包括塞尔特——它是最普遍被使用的药物。
Tamoxifen was the first estrogen modulator shown to increase survival and reduce the risk of breast cancer recurrence.
三苯氧胺是第一个雌激素调节剂，可增加患者的生存率和降低乳腺癌复发的危险。
About 500, 000 women in the United States take tamoxifen, which cuts in half the chances of a breast cancer recurrence.
美国大约有50万妇女在服用他莫昔芬，这使得乳腺癌的复发率下降了一半。
Prof Evans is leading a study into the use of the drug tamoxifen, which may reduce the risk of breast cancer by 40 per cent.
埃文教授正在领头研究有关三苯氧胺（一种抗肿瘤药）的使用，该药可以将乳腺癌的危险性减小40%。
Methods The clinical data and ct findings of 36 patients with fatty liver caused by oral tamoxifen were analysed retrospectively.
方法：回顾性分析36例乳腺癌术后口服三苯氧胺致脂肪肝患者的CT及临床资料。
Objective To investigate the effects of tamoxifen (tam) on proliferation of SHG-44 glioma cells and explore its possible mechanism.
目的研究三苯氧胺(TAM)对人脑胶质瘤细胞SHG - 44增殖的影响并探究其可能机制。
It found that using these interfering drugs - including Prozac, Paxil or Zoloft - can virtually wipe out the benefit tamoxifen provides.
它发现，使用这些干扰药物——包括百忧解、帕罗西汀以及左洛复——可以消除他莫昔芬的药物作用。
Guha N. at University of California at Berkeley and colleagues also found use of soy foods does not seem to interfere with tamoxifen efficacy.
加州大学伯克利分校的N .古哈与同事们也发现豆类食品的作用并不会干涉它莫西芬的药效。
Tamoxifen can induce or exacerbate menopausal symptoms but reduces incidence of contralateral breast cancer and lowers serum cholesterol.
三苯氧胺会诱发或加重绝经期症状，但可减少对侧乳腺癌的发生率，降低血清胆固醇。
Prior to this study, tamoxifen was used for the treatment and prevention of oestrogen receptor-positive breast cancers, Dr. Pinkerton said.
Pinkerton博士称，在该项研究之前，医生用三苯氧胺治疗和预防雌激素受体阳性乳腺癌。
When it comes to breast cancer prevention, drugs such as tamoxifen can help, Pollak says, "but here we're seeing important risk reductions with a vitamin."
就乳腺癌的防治而言，象三苯氧胺之类的药物是有作用的，Pollak说“但此处我们看到了维生素降低肿瘤风险的重要作用。
The objective response to antiestrogen tamoxifen (TAM)in advanced breast cancer with respect to its estrogen receptor (ER) Status was studied in 55 patients.
在55例晚期乳癌病人中研究了抗雌激素他莫昔芬（TAM）治疗效果和乳癌雌激素受体（ER）状态的关系。
In the study, cancer returned in 16 percent of women taking tamoxifen plus Prozac, Paxil, or Zoloft -- but recurred in only 7.5 percent of women on tamoxifen alone.
在实验中，16%服用他莫昔芬的同时使用百忧解、帕罗西汀以及左洛复得女性乳腺癌复发，但是在单独服用他莫昔芬的女性中仅仅7.5%的复发率。
The researchers found that if patients took Seroxat for 25 per cent of the time they were on tamoxifen, they were 24 per cent more likely to die from breast cancer.
调查者发现，如果病人在他们服用它莫西芬的25%的时间内服用塞尔特，他们死于乳腺癌的几率将增加24%。 如果时间增加到50%，死亡几率上升至54。
Researchers used members' medical records to identify 353 women taking tamoxifen plus other drugs that might interfere with it, and 945 women taking tamoxifen alone.
研究人员利用其成员的病例发现了353名服用他莫昔芬以及其它可能产生干扰的药物的妇女，以及945名只服用他莫昔芬的妇女。
But the authors stressed that women should not stop taking tamoxifen and that their study does not imply that Seroxat causes or influences the course of breast cancer.
但是作者同时也强调妇女们不应该因此停止服用它莫西芬，并且，他们的研究并不意味着是塞尔特引起或影响了乳腺癌的病状。
应用推荐